Showing results (71-80 of 1,873) with videos related to

Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|December 21, 2004
Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic optionsDuncan F Rogers
Pulmonary Pharmacology & Therapeutics|December 21, 2004
Phosphodiesterase 4-selective inhibition: novel therapy for the inflammation of COPDPeter Jeffery
Pulmonary Pharmacology & Therapeutics|June 9, 2005
Effect of reproterol either alone or combined with disodium cromoglycate on airway responsiveness to methacholineFrank Kanniess, Rudolf A Jörres, Helgo Magnussen
Pulmonary Pharmacology & Therapeutics|June 9, 2005
The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lungG Sandra Tjabringa, Klaus F Rabe, Pieter S Hiemstra
Pulmonary Pharmacology & Therapeutics|June 9, 2005
Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patientsEric Derom, Veerle Van De Velde, Sandra Marissens, et al.
Pulmonary Pharmacology & Therapeutics|June 9, 2005
IL-1beta induces IL-8 in bronchial cells via NF-kappaB and NF-IL6 transcription factors and can be suppressed by glucocorticoidsMichael R Edwards, Naofumi Mukaida, Malcolm Johnson, et al.
Pulmonary Pharmacology & Therapeutics|June 9, 2005
Recombinant human relaxin reduces hypoxic pulmonary hypertension in the ratCarol A Tozzi, George J Poiani, Nansie A McHugh, et al.
Pulmonary Pharmacology & Therapeutics|September 24, 2005
Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonideR Nave, W Meyer, R Fuhst, et al.
Pulmonary Pharmacology & Therapeutics|September 24, 2005
Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPDD D Briggs, H Covelli, R Lapidus, et al.
Pageof 188